Skip to main content
Journal of the National Medical Association logoLink to Journal of the National Medical Association
. 1993 Apr;85(4):293–296.

Short-term declines in CD4 levels associated with cocaine use in HIV-1 seropositive, minority injecting drug users.

N S Siddiqui 1, L S Brown Jr 1, R W Makuch 1
PMCID: PMC2571897  PMID: 8478971

Abstract

This study evaluates the association of cocaine use with short-term change in CD4 counts among human immunodeficiency virus type 1 (HIV-1) seropositive, minority injecting drug users prior to the introduction of zidovudine (AZT). Ninety-eight HIV-1 seropositive subjects were recruited from six inner-city, methadone maintenance clinics. A baseline assessment included a short questionnaire regarding drug behavior and quantitation of CD4 cell counts. These measures were repeated on all subjects 3 to 4 months later. Thirty-eight subjects reported using cocaine between baseline and 4-month follow-up evaluations. Males and African Americans were more likely to be cocaine users (P < .01). Cocaine users were more likely to engage in heroin and needle use (P < .001). Cocaine users experienced a significant decline in CD4 cells compared with nonusers (P = .013); no marked difference in CD4 decline was noted between heroin users and nonusers (P = .19). Multivariate analysis showed that a decline in CD4 counts was 2.82 times more likely to occur in cocaine users than in cocaine nonusers (90% two-sided confidence interval of 1.08, 7.37). These findings support the hypothesis of a possible link between cocaine use and short-term CD4 decline in HIV-1 seropositive injecting drug users.

Full text

PDF
295

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brown S. M., Stimmel B., Taub R. N., Kochwa S., Rosenfield R. E. Immunologic dysfunction in heroin addicts. Arch Intern Med. 1974 Dec;134(6):1001–1006. [PubMed] [Google Scholar]
  2. Des Jarlais D. C., Friedman S. R., Marmor M., Cohen H., Mildvan D., Yancovitz S., Mathur U., el-Sadr W., Spira T. J., Garber J. Development of AIDS, HIV seroconversion, and potential co-factors for T4 cell loss in a cohort of intravenous drug users. AIDS. 1987 Jul;1(2):105–111. [PubMed] [Google Scholar]
  3. Heathcote J., Taylor K. B. Immunity and nutrition in heroin addicts. Drug Alcohol Depend. 1981 Nov;8(3):245–255. doi: 10.1016/0376-8716(81)90068-5. [DOI] [PubMed] [Google Scholar]
  4. Kaslow R. A., Blackwelder W. C., Ostrow D. G., Yerg D., Palenicek J., Coulson A. H., Valdiserri R. O. No evidence for a role of alcohol or other psychoactive drugs in accelerating immunodeficiency in HIV-1-positive individuals. A report from the Multicenter AIDS Cohort Study. JAMA. 1989 Jun 16;261(23):3424–3429. [PubMed] [Google Scholar]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

RESOURCES